Your browser doesn't support javascript.
loading
Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer.
Tokiwa, Suguru; Shimmura, Hiroaki; Nomura, Shuhei; Watanabe, Ryota; Kurita, Minoru; Yoshida, Naoto; Yamashita, Kaori; Nishikawa, Yoshitaka; Kouzmenko, Alexander; Kato, Shigeaki.
Afiliação
  • Tokiwa S; Department of Urology, Jyoban Hospital, Tokiwa Foundation, Iwaki, Fukushima, Japan.
  • Shimmura H; Department of Urology, Jyoban Hospital, Tokiwa Foundation, Iwaki, Fukushima, Japan.
  • Nomura S; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Watanabe R; Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo.
  • Kurita M; Research Institute of Innovative Medicine, Tokiwa Foundation, Iwaki.
  • Yoshida N; Department of Urology, Jyoban Hospital, Tokiwa Foundation, Iwaki, Fukushima, Japan.
  • Yamashita K; Department of Urology, Jyoban Hospital, Tokiwa Foundation, Iwaki, Fukushima, Japan.
  • Nishikawa Y; Department of Urology, Jyoban Hospital, Tokiwa Foundation, Iwaki, Fukushima, Japan.
  • Kouzmenko A; Department of Urology, Jyoban Hospital, Tokiwa Foundation, Iwaki, Fukushima, Japan.
  • Kato S; Department of Health Informatics, School of Public Health, Kyoto University, Kyoto, Japan.
Res Rep Urol ; 9: 225-232, 2017.
Article em En | MEDLINE | ID: mdl-29264358
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article